Trius Investigator Site 128 — Las Vegas, Nevada

Trius Investigator Site 128 is a clinical research site located in Las Vegas, Nevada, United States 89109.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Trius Investigator Site 128 has participated in 1 clinical trials.

Therapeutic areas: Major Cutaneous Abscess, Cellulitis, Erysipelas.

Sponsors: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trius Investigator Site 128?

Trius Investigator Site 128 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trius Investigator Site 128 conducted?

Trius Investigator Site 128 has 1 clinical trials on record. Their work covers Major Cutaneous Abscess, Cellulitis, Erysipelas.

Is Trius Investigator Site 128 accredited by Crixeo Health?

Trius Investigator Site 128 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trius Investigator Site 128?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.